Digital rendering of Arcalis' new manufacturing site in Minamisoma City, Japan.

Arc­turus Ther­a­peu­tics hand­ed $115M from Japan­ese gov­ern­ment to de­vel­op pro­duc­tion site

San Diego-based RNA biotech Arc­turus Ther­a­peu­tics’ man­u­fac­tur­ing op­er­a­tions in Japan have been giv­en a fi­nan­cial boost from the lo­cal gov­ern­ment.

Ar­calis Co., Ltd., its pro­duc­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA